Facebook Linkedin Youtube X-twitter Instagram
Professional Syndicates Complex, Sharif Abdel Hamid Sharaf Street, 31, Amman, Jordan
About Jordan
Login
Dyslipidemia Management
Hypertension Clinical Protocols
LAAO (Watchman) vs DOAC (CHAMPION-AF):
Catheter-Directed Therapy vs Anticoagulation in Intermediate-Risk PE (HI-PEITHO):
ACC 2026 Scientific sessions, March 29, 2026)
Angio-Derived FFR -ACC 2026
Practice-Changing Interventional Cardiology — ACC.26 (Bullet Summary)
Impella + PCI vs PCI Alone (STEMI-DTU): No Benefit… More Harm
LDL <55 vs <70 mg/dL (Ez-PAVE): Lower is Better
New-generation Guide extension catheter (CrossFAST)
Global Blood Pressure Targets and Treatment Thresholds Across Major Guidelines (2025 Update)
Center of Excellence Criteria For Transcatheter Tricuspid Valve Interventions (TTVI )— Key Points (2026)
A1c Targets in Older Adults with Type 2 Diabetes — Key Points
Hypercortisolism & Resistant Hypertension — MOMENTUM (ACC.26)
Off-the-Shelf Conduit for CABG — First-in-Human (2026)
SGLT2 Inhibitors in HF — Barriers in Jordan (Mixed-Methods Study, 2026)
Paradigm Change Coming in Secondary Stroke Prevention: OCEANIC-STROKE (2026)
IVUS-Guided PCI — New Trial Insights (ACC 2026)
Rethinking “Time is Muscle”
CTO PCI — Key Points (JACC 2026)
Calcium Supplements & Recurrent CVD Risk (JAHA 2026)
Cardiogenic Shock — Unexpected Insight.
Postoperative Atrial Fibrillation After Cardiac Surgery: Prevention and Management
Bedside PDA Closure in Premature Infant — Key Points
Corneal Reflex & Imminent Death -Key Points
SELUTION DeNovo Trial — SCAI 2026 Highlights
Heart Failure With Mildly Reduced Ejection Fraction Statement
ApoB vs LDL-C for Lipid Targets (JAMA 2026)
Potassium-Enriched Salt in Hypertension، Meta-analysis 2026 (JACC) — Key Points
Key Trends in Cardiac CT
American Hospital Association launched a 3-year initiative to help hospitals implement:
Acute HF Congestion: Practical Tips From ACC 2026 (Medscape Commentary) :
Subclinical AF Burden Alone Not Enough for Anticoagulation Decisions: NOAH-AFNET 6 Analysis
Best States for Nurses — 2026
Higher Aldosterone-Renin Ratio (Primary Aldosteronism Spectrum) Linked to Higher Stroke and AF Risk in ARIC Cohort
Heart Failure & Hypertension — PURE Study (2026)
Clopidogrel Monotherapy After DAPT — Key Points (SCAI 2026)
Blood Pressure Lowering Across CKD Stages: Meta-Analysis Findings
Early Activity After MI Appears Safe
EuroPCR 2026: BATMAN (Balloon-Assisted Translocation(slpitting) of the Mitral Anterior Leaflet) Expands TMVR Options in High-Risk Patients
EuroPCR 2026: Can Coronary Arteries Move Naturally Again After PCI?
EuroPCR 2026: When Both CAD and Aortic Stenosis Coexist, Treat the Valve First
EuroPCR 2026: New Balloon-Assisted Technique For LVOT Protection Before TMVR
Less Oxygen, Better Outcomes— REDOX-AHF Challenges Traditional Oxygen Therapy in Acute Heart Failure
Inflammation: A Common Thread Across All Heart Failure Spectrum— POSEIDON Study
Expanding the Window for Thrombectomy in Large-Vessel Ischemic Stroke
MRAs in HFmrEF and HFpEF — Where Do We Stand in 2026?
EuroPCR 2026 Dominates TCTMD’s Top Cardiovascular Stories of May
AATS 2026 :
Heart Rhythm 2026:
ATS 2026 : (American Thoracic Society International Conference, 20 May 2026)
From the Ongoing ESH 2026 Scientific Focus: Children & AdolescentsGdańsk, Poland | 29 May – 1 June 2026
EuroPCR 2026: Drug-Coated Balloon (DCB) Strategy Shows Promise in Complex PCI
TAVI Before 65? New Data Revive the Debate Between Catheter and Surgical Valve Replacement
A New Proposal to the FDA: Should Clinical AI Be Licensed Like Physicians Instead of Regulated as a medical device?
ESC Heart Failure 2026 (Barcelona | May 17–20, 2026):
A new RNA-based Therapy (microRNA) Change Post-MI Remodeling?
Can Tirofiban Improve 90-Day Outcomes After Poor Response to Stroke Thrombolysis?
EAS 2026 Highlights: During the ongoing EAS Congress 2026 in Athens
NEJM / EAS 2026 – Heart-2 Trial
Single Versus Dual Antiplatelet Therapy After TAVR in Patients Without an Indication for Oral Anticoagulation
Safer NSAID Choice for AF Patients Receiving DOACs
A multicenter European study with prominent participation and first authorship by a Jordanian investigator.
The Lancet / EuroPCR 2026
ACC/AHA 2026
Tirofiban After Rescue therapy in CVA (Failed Stroke Thrombolysis): A New Opportunity, Not a New Standard
European Heart Journal 2026
1-Month DAPT After Current-Generation DES PCI May Be Best for High-Bleeding-Risk Patients
CliHeart Rhythm (June 2026)ck here
EuroPCR 2026
1-Month DAPT After Current-Generation DES PCI May Be Best for High-Bleeding-Risk Patients
JAMA Cardiology Meta-analysis: Prasugrel the Best P2Y12 Inhibitor After PCI? Source TCTMD (June 5, 2026)
ASE 2026: New Guideline Makes Live 3D Imaging the New Standard for Mitral TEER Guidance
From PARTNER 3 to PARTNER 2A: TAVI Passes the 10-Year Durability Test
Gout Linked to Higher Stroke Risk in AF Patients
ESPRIT: Turning the <120 mmHg Target Into Real-World Practice.